[Mass screening for prostate cancer--how to eliminate clinically insignificant cancer].
The ultimate aim of the mass screening program for prostate cancer is to decrease prostate cancer mortality, which can be demonstrated only in a well-designed and well-controlled trial comparing screened and unscreened populations. However, no trials have been performed to demonstrate the effect of this program. Some reports claimed that such a program includes the high possibility of detecting clinically insignificant cancer, for example, latent cancer. In this paper, early cancer detection and treatment in mass screening program are discussed.
Imai
K
K
Dept. of Urology, Atagawa Onsen Hospital.
Kubota
H
H
D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D015996:Survival Rate
D017430:Prostate-Specific Antigen